Aslani, Iris .
HRN: 24-25-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
05/13/2024
05/20/2024
IV
27.5
OD
Pcap , T/c CNSInfectin
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes